← Leaderboards
Linda A Dimeglio
Indiana Univ-Purdue Univ At Indianapolis
$12,449,185
Attributed
$20,656,122
Total exposure
24
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,656,122 · 24
By mechanism
K12$13,003,302 · 1
U01$4,736,949 · 3
DP3$2,131,607 · 1
K23$559,879 · 1
M01$224,385 · 18
Top collaborators
- David Matthew Maahs6 shared
- Bruce A. Buckingham1 shared
- Kimberly Driscoll1 shared
- Korey K Hood1 shared
- Robert Slover1 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- C. Conrad Johnston$0
- Michael J Econs$17,934,951
- James E Klaunig$1,879,862
- Tatiana M. Foroud$164,603,187
- Charles H Turner$5,408,679
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelResourcesInsulin-Dependent Diabetes MellitusDiabetes MellitusBone DensityFundingInstitutionDesignOsteogenesis ImperfectaAdultClinical ResearchRecruitment ActivityProtocols DocumentationUnited States National Institutes Of HealthHyperglycemiaUniversitiesInsulinGrantHuman SubjectPhysiciansIndianaInvestigationRandomizedHuman Therapy Evaluation
Grant awards (51)
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)$3,723,874
K12 · FY2025 · DK
Neurocognitive Effects of Type 1 Diabetes in Young Children: Indiana University Clinical Center$515,461
U01 · FY2025 · DK · contact PI
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)$3,163,120
K12 · FY2024 · DK
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)$562,929
K12 · FY2024 · DK
Neurocognitive Effects of Type 1 Diabetes in Young Children: Indiana University Clinical Center$270,932
U01 · FY2024 · DK · contact PI
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)$2,573,707
K12 · FY2023 · DK
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)$400,000
K12 · FY2023 · DK
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)$2,579,672
K12 · FY2022 · DK
Type 1 Diabetes TrialNet at Indiana University Clinical Center$449,990
U01 · FY2018 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$422,729
U01 · FY2017 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$458,609
U01 · FY2016 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$422,729
U01 · FY2015 · DK · contact PI
Using a Closed-Loop System Plus Behavioral Supports in Preschoolers with Diabetes$2,131,607
DP3 · FY2014 · DK
Type 1 Diabetes TrialNet at Indiana University Clinical Center$247,303
U01 · FY2013 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$11,642
U01 · FY2013 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$424,925
U01 · FY2012 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$689,367
U01 · FY2011 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$823,262
U01 · FY2010 · DK · contact PI
BISPHOSPHONATE THERAPY FOR CHILDHOOD OSTEOPOROSIS$1,323
M01 · FY2008 · RR · contact PI
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$800
M01 · FY2008 · RR · contact PI
ORAL BISPHOSPHONATE THERAPY FOR ADULTS WITH OSTEOGENESIS IMPERFECTA$145
M01 · FY2008 · RR · contact PI
PATHOGENESIS OF OSTEOPOROSIS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS$58
M01 · FY2008 · RR · contact PI
BISPHOSPHONATE THERAPY FOR CHILDHOOD OSTEOPOROSIS$15,572
M01 · FY2007 · RR · contact PI
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$9,412
M01 · FY2007 · RR · contact PI
ORAL BISPHOSPHONATE THERAPY FOR ADULTS WITH OSTEOGENESIS IMPERFECTA$1,710
M01 · FY2007 · RR · contact PI
PATHOGENESIS OF OSTEOPOROSIS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS$683
M01 · FY2007 · RR · contact PI
BISPHOSPHONATE THERAPY FOR CHILDHOOD OSTEOPOROSIS$28,079
M01 · FY2006 · RR · contact PI
BIPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$12,121
M01 · FY2006 · RR · contact PI
ORAL BISPHOSPHONATE THERAPY FOR ADULTS WITH OSTEOGENESIS IMPERFECTA$2,828
M01 · FY2006 · RR · contact PI
PATHOGENESIS OF OSTEOPOROSIS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS$1,212
M01 · FY2006 · RR · contact PI
BISPHOSPHONATE THERAPY FOR CHILDHOOD OSTEOPOROSIS$31,809
M01 · FY2005 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$28,938
M01 · FY2005 · RR
ORAL BISPHOSPHONATE THERAPY FOR ADULTS WITH OSTEOGENESIS IMPERFECTA$3,093
M01 · FY2005 · RR
PATHOGENESIS OF OSTEOPOROSIS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS$2,651
M01 · FY2005 · RR
CONTINUOUS INSULIN INFUSION VERSUS INSULIN INJECTION THERAPY$221
M01 · FY2005 · RR
Mentored Patient Oriented Research Career Development Aw$116,648
K23 · FY2004 · RR
Bisphosphonate Therapy for Childhood Osteoporosis$41,366
M01 · FY2004 · RR
Biphosphonate Therapy for Osteogenesis Imperfecta$38,127
M01 · FY2004 · RR
Oral Bisphosphonate Therapy for Adults with Osteogenesis Imperfecta$3,738
M01 · FY2004 · RR
Pathogenesis of Osteoporosis In Young Children with Cystic Fibrosis$499
M01 · FY2004 · RR
Mentored Patient Oriented Research Career Development Aw$114,038
K23 · FY2003 · RR
Mentored Patient Oriented Research Career Development Aw$111,501
K23 · FY2002 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$0
M01 · FY2002 · RR
Mentored Patient Oriented Research Career Development Aw$109,041
K23 · FY2001 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$0
M01 · FY2001 · RR
Mentored Patient Oriented Research Career Development Aw$108,651
K23 · FY2000 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$0
M01 · FY2000 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$0
M01 · FY2000 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$0
M01 · FY2000 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$0
M01 · FY2000 · RR
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA$0
M01 · FY2000 · RR